NCT02453022 - A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 18, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Danirixin HBr 50 mg IR Tablet

Danirixin HBr 50 mg IR Tablet is white, film-coated, oval-shaped tablet for oral administration.

DRUG

Danirixin FB 50 mg IR Tablet

Danirixin FB 50 mg IR Tablet is white, film-coated, capsule-shaped tablet for oral administration.

DRUG

Prilosec (omeprazole) 40mg Delayed-Release capsule

Prilosec (omeprazole) 40 mg delayed-release capsule is opaque, hard gelatin, apricot, and amethyst colored capsules, coded 743 on cap and PRILOSEC 40 on the body for oral administration.

Trial Locations (1)

66211

GSK Investigational Site, Overland Park